Transcriptomic analysis of human primary T cells after short-term leucine-deprivation and evaluation of kinase GCN2's

Aurore Dougé1,2, Gwendal Cueff3, Céline Keime4

  • 1Service d'oncologie médicale, CHU Gabriel Montpied, Clermont-Ferrand, France.

Plos One
|February 18, 2025
PubMed

Insights

Short leucine deprivation in T cells enhances gene expression via GCN2 kinase. This metabolic modulation strategy shows promise for improving Chimeric Antigen Receptor T (CAR-T) cell cancer therapies.

Area of Science:

  • Immunology
  • Cellular Metabolism
  • Cancer Therapy

Background:

  • Chimeric Antigen Receptor T (CAR-T) cells are a key cancer treatment strategy.
  • Optimizing CAR-T cell efficacy involves modulating their metabolism.
  • Activating GCN2 kinase via amino acid deprivation can induce transgene expression.

Purpose of the Study:

  • Investigate the impact of leucine deprivation on human T cells.
  • Determine the role of GCN2 kinase in differential gene expression.
  • Evaluate amino acid starvation as a method to enhance CAR-T cell efficacy.

Main Methods:

  • Primary human T cells were cultured with or without leucine.
  • RNA-sequencing technology was used to analyze gene expression changes.
  • GCN2 kinase inhibitor was used to assess kinase dependency.

Main Results:

  • Leucine deprivation altered 3,431 genes in T cells.
  • Key pathways like TNFα signaling and interferon-γ response were enriched.
  • GCN2 kinase mediated 59% of the observed gene expression changes.

Conclusions:

  • Short-term leucine deprivation significantly impacts T cell gene expression.
  • GCN2 kinase plays a crucial role in mediating these metabolic responses.
  • Combining amino acid starvation with transient gene overexpression is a promising strategy for CAR-T cell enhancement.